Abstract
The nephrologist is often called upon to aid in the treatment of poisoning in several ways: for guidance in the use of forced diuresis, for dialysis, and for expertise in sorbent hemoperfusion. Frequently consultation is sought for patients known to have ingested drugs with known rates of removal by dialysis and hemoperfusion. Advice may also be sought for substance removal where the exposure may be to a recently marketed drug or chemical for which there is scanty information on active drug removal with artificial organs. It is the purpose of this chapter to outline the factors governing active drug removal, to suggest areas in which drug removal may be invaluable or worthless, and to give guidelines for the employment of drug removal techniques.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
National Center for Health Statistics: DHEW, Public Health Service (HRA), 1977.
Jones DIR: Self poisoning with drugs: The last 20 years in Sheffield. Br Med J 1:28–20, 1977.
Litovitz T, Veltri J: 1984 Annual report of the American Association of Poison Control Centers. Am J Emergency Med 3:423, 1985.
Clemmesen C, Nilsson E: Therapeutic trends in the treatment of barbiturate poisoning: The Scandinavian method. Clin Pharmacol Ther 2:220–229, 1961.
Haddad LM: A general approach to the emergency management of poisoning. In: LM Haddad, JF Winchester, eds, Clinical Management of Poisoning and Drug Overdose. WB Saunders, Philadelphia, pp 4–17, 1983.
Haddad LM: A general approach to poisoning. In: JF Winchester, ed, Office Procedures: Office Management of Poisoning. Hanley and Belfus, Philadelphia, pp 325–342, 1986.
Proudfoot AT: Salicylates and salicylamides. In: LM Haddad, JF Winchester, eds, Clinical Management of Poisoning and Drug Overdose. WB Saunders, Philadelphia, pp 575–586, 1983.
Winters RW, White JS, Hughes MC, Ordway NC: Disturbances of acid-base equilibrium in salicylate intoxication. Pediatrics 23:260, 1959.
Gabow PA, Anderson RJ, Potts DE, Schrier RW: Acid-base disturbances in the salicylate-intoxicated adult. Arch Intern Med 138:1481, 1978.
Anderson RJ, Potts DE, Gabow PA, Rumack BH, Schrier RW: Unrecognized adult salicylate intoxication. Ann Intern Med 85:745, 1976.
Winchester JF: Methanol, isopropyl alcohol, higher alcohols, ethylene glycol, cellosolves, acetone and oxalate. In: LM Haddad, JF Winchester, eds, Clinical Management of Poisoning and Drug Overdose. WB Saunders, Philadelphia, pp 393–409, 1983.
Seyffart G: Meprobamate and related drugs. In: LM Haddad, JF Winchester, eds, Clinical Management of Poisoning and Drug Overdose. WB Saunders, Philadelphia, pp 520–526, 1983.
Schwartz HS: Acute meprobamate poisoning with gastrostomy and removal of a drug containing mass. N Engl J Med 295:1177, 1976.
Renzi FP, Donovan JW, Martin TG, Morgan L, Harrison EF: Concomitant use of activated charcoal and n-acetyl cysteine. Ann Emerg Med 14:568–572, 1985.
Winchester JF: Active methods for detoxification: Oral sorbents, forced diuresis, hemoperfusion, and hemodialysis. In: LM Haddad, JF Winchester, eds, Clinical Management of Poisoning and Drug Overdose. WB Saunders, Philadelphia, pp 154–169, 1983.
Okonek S, Hofman A, Hennigsen B: Efficacy of gut lavage, haemodialysis, and haemoperfusion in the therapy of paraquat and diquat intoxication. Arch Toxicol 36:43, 1974.
Shepherd SM, Litovitz TL: Antidotes. In: JF Winchester, ed, Office Procedures: Office Management of Poisoning. Hanley and Belfus, Philadelphia, pp 425–440, 1986.
Prowse K, Pain M, Marston AD, Cummings G: The treatment of salicylate poisoning using mannitol and forced alkaline diuresis. Clin Sci 38:327, 1970.
Winchester JF: Lithium. In: LM Haddad, JF Winchester, eds, Clinical Management of Poisoning and Drug Overdose. WB Saunders, Philadelphia, pp 372–379, 1983.
Prescott LF, Balali-Mood M, Critchley JA, Johnstone AF, Proudfoot AT: Diuresis or urinary alkalinization in salicylate poisoning? Br Med J 285:1383–1386, 1982.
Graham T: Bakerian lecture on osmotic force. Philos Trans R Soc London, p 177, 1854.
Abel JJ, Rowntree LG, Turner BB: On the removal of diffusible substances from the circulating blood of living animals by dialysis. Clin Pharmacol ther 5:275–316, 1913.
Doolan PD, Walsh WP, Kyle LH, Wishinsky H: Acetylsalicylic acid intoxication: A proposed method of treatment. JAMA 146:105–106, 1951.
Schreiner GE, Berman LB, Griffin J, Feys J: Specific therapy for salicylism. N Engl J Med 253:213–217, 1955.
Schreiner GE: The role of hemodialysis (artificial kidney) in acute poisoning. Arch Intern Med 102:896–913, 1958.
Maher JF, Schreiner GE: Editorial review: The dialysis of poisons. Trans Am Soc Artif Intern Organs 9:385–394, 1963.
Maher JF, Schreiner GE: Editorial review: The clinical dialysis of poisons. Trans Am Soc Artif Intern Organs 11:349–365, 1965.
Maher JF, Schreiner GE: The dialysis of poisons and drugs. Trans Am Soc Artif Intern Organs 13:369–393, 1967.
Maher JF, Schreiner GE: The dialysis of poisons and drugs. Trans Am Soc Artif Intern Organs 14:440–453, 1968.
Maher JF, Schreiner GE: Current status of dialysis of poisons and drugs. Trans Am Soc Artif Intern Organs 15:461–477, 1969.
Schreiner GE: Dialysis of poisons and drugs — annual review. Trans Am Soc Artif Intern Organs 16:544–568, 1970.
Schreiner GE, Teehan BP: Dialysis of poisons and drugs — annual review. Trans Am Soc Artif Intern Organs 17:513–544, 1971.
Schreiner GE, Teehan BP: Dialysis of poisons and drugs — annual review. Trans Am Soc Artif Intern Organs 18:563–599, 1972.
Knepshield JH, Schreiner GE, Lowenthal DT, Gelfand MC: Dialysis of poisons and drugs — annual review. Trans Am Soc Artif Intern Organs 19:590–631, 1973.
Winchester JF, Gelfand MC, Knepshield JH, Schreiner GE: Dialysis and hemoperfusion of poisons and drugs — update. Trans Am Soc Artif Intern Organs 23:762–842, 1972.
Maher JF, Hirszel, P, Galen MA, Chamberlin M, Hohnadel DC: Enhanced peritoneal transport with dipyridamole. Trans Am Soc Artif Intern Organs 23:219–223, 1977.
Reuler JB, Parker RA: Peritoneal dialysis in the management of hypothermia. JAMA 240:2289, 1978.
Gibson TP, Atkinson AJ: Effect of changes in inter-compartmental rate constants on drug removal during hemoperfusion. J Pharm Sci 67:1178–1179, 1978.
Gibson TP, Lucas SV, Nelson HA, Atkinson AJ, Okita GT, Ivanovich P: Hemoperfusion removal of digoxin from dogs. J Lab Clin Med 91:673–682, 1978.
Hoy WE, Gibson TP, Rivero AJ, Jain JK, Talley TT, Bayer RM, Montondo DF, Freeman RB: XAD-4 resin hemoperfusion for digitoxic patients with renal failure. Kidney Int 23:79–82, 1983.
Fairshter RD, Rosen SM, Smith WR, Glauser FL, McRae DM, Wilson AF: Paraquat poisoning. New aspects of therapy. Q J Med 45:180, 1976.
Muirhead EE, Reid AF: Resin artificial kidney. J Lab Clin Med 33:841–844, 1948.
Yatzidis H: A convenient haemoperfusion micro-apparatus over charcoal for the treatment of endogenous and exogenous intoxications. Its use as an artificial kidney. Proc Eur Dial Transplant Assoc 1:83–86, 1964.
Yatzidis H, Voudiclari S, Oreopoulos D, Tsaparas D, Triantaphyllidis D, Gavras C, Stavroulaki A: Treatment of severe barbiturate poisoning. Lancet 2:216–217, 1965.
Chang TMS: Artificial Cells. CC Thomas, Springfield, IL, 1972.
Chang TMS, Coffey JF, Lister C, Taroy E, Stark A: Methaqualone and glutethimide clearance by the ACAC microcapsule artificial kidney: In vitro and in patients with acute intoxication. Trans Am Soc Artif Intern Organs 19:87–91, 1973.
Rosenbaum JL, Winsten S, Kramer MS, Moros J, Raja R: Resin hemoperfusion in the treatment of drug intoxication. Trans Am Soc Artif Intern Organs 16:134–140, 1970.
Gelfand MC, Winchester JF, Knepshield JH, Hanson KM, Cohan SL, Strauch BS, Geoly KL, Kennedy AC, Schreiner GE: Charcoal hemoperfusion in the treatment of severe drug overdosage. Trans Am Soc Artif Intern Organs 23:599–604, 1977.
Ehlers SM, Zaske DE, Sawchuk RJ: Massive theophylline overdose. Rapid elimination by charcoal hemoperfusion. JAMA 240:474, 1978.
Trafford JAP, Jones RH, Evans R, Sharp P, Sharpstone P, Cook J: Haemoperfusion with R-004 amberlite resin for treating acute poisoning. Br Med J 2:1453, 1977.
Rosenbaum JL, Kramer MS, Raja R: Resin hemoperfusion for acute drug intoxication. Arch Intern Med 136:263, 1976.
Vale JA, Rees AJ, Widdop B, Goulding R: Use of charcoal haemoperfusion in the management of severely poisoned patients. Br Med J 1:5–9, 1975.
Winchester JF, Gelfand MC, Tilstone WJ: Hemoperfusion in drug intoxication: Clinical and laboratory aspects. Drug Metab Rev 8:69–104, 1978.
Winchester JF, Tilstone WJ, Edwards RO, Gilchrist T, Kennedy AC: Hemoperfusion for enhanced drug elimination — a kinetic analysis in paracetamol poisoning. Trans Am Soc Artif Intern Organs 20:358–363, 1974.
Winchester JF, Rhaman A, Tilstone WJ, Kessler A, Mortensen L, Schreiner GE, Schein PS: Sorbent removal of adriamycin in vitro and in vivo. Cancer Treat Rep 63:1787–1793, 1979.
Uldall PR: Controlled trial of resin hemoperfusion for the treatment of drug overdose at Toronto Western Hospital (TWH). Trans Am Soc Artif Intern Organs 28:676–677, 1982.
Maher JF: In discussion on hemoperfusion for poisoning — Is it really necessary? In: GE Schreiner, JF Winchester, eds, Controversies in Nephrology, Vol 2. Georgetown Nephrology Press, Washington DC, p 228, 1980.
Chazan JA, Garella S: Glutethimide intoxication: A prospective study of 70 patients treated conservatively without hemodialysis. Arch Intern Med 128:215, 1971.
Lorch JA, Garella S: Hemoperfusion to treat intoxications. Ann Intern Med 91:301, 1979.
Hadden J, Johnson K, Smith S, Price L, Giardana E: Acute barbiturate intoxication: Concepts in management. JAMA 209:893–901, 1969.
Seyffart G: Plasmapheresis in treatment of acute intoxication. Trans Am Soc Artif Intern Organs 28:673–676, 1982.
Marbury T, Mahoney J, Juncos L, Conti R, Cade R: Advanced digoxin toxicity in renal failure — Treatment with charcoal hemoperfusion. South Med J 72:279, 1979.
Tobin M, Cerra F, Steinvach J, Mookerjee B: hemoperfusion in digitalis intoxication: A comparative study of coated versus uncoated charcoal. Trans Am Soc Artif Intern Organs 23:730, 1977.
Colburn WA: Specific antibodies and Fab fragments to alter the pharmacokinetics and reverse the pharmacologic/toxicologic effects of drugs. Drug Metab Rev 11:233, 1980.
Oldfield EH, Dedrick RL, Yeager RL, Clark WC, DeVroom HL, Chatterji DC, Doppman JL: Reducd systemic drug exposure by continuous intrarterial chemotherapy with hemoperfusion of regional venous drainage. J Neurosurg 163:726–732, 1985.
Schwartz RD: Deferoxamine and aluminum removal. Am J Kid Dis 6:358–364, 1985.
Brown DJ, Dawborn JK, Ham KN, Xipell JM: Treatment of dialysis osteomalacia with desferrioxamine. Lancet 2:343–347, 1982.
Chang TMS, Barre P: Effect of desferrioxamine on removal of aluminium and iron by coated charcoal haemoperfusion and haemodialysis. Lancet 2:1051–1054, 1983.
Hakim RM, Schulman JM, Lazarus JM: Hemoperfusion in the treatment of aluminum (Al) and iron (Fe) induced bone disease. Abstr Am Soc Nephrol 18:65a, 1985.
Andress DL, Maloney NA, Endres DB, Sherrard DJ: Aluminum-associated bone disease in chronic renal failure: High prevalence in a long term dialysis population. J Bone Miner Res 1:391–398, 1986.
Arieff AI: Aluminum and the pathogenesis of dialysis encephalopathy. Am J Kid Dis 6:317–321, 1985.
Bregman H, Gelfand MC, Winchester JF, Manz HJ, Knepshield JH, Schreiner GE: Iron overload-associated myopathy in patients on maintenance haemodialysis. A histocompatibility linked disorder. Lancet 2:882–885, 1980.
Winchester JF: Management of iron overload. Seminars Nephrol 4 (Suppl 1):22–26, 1986.
Falk RJ, Mattern WD, Lamanna RW, et al.: Iron removal during continuous ambulatory peritoneal dialysis using deferoxamine. Kidney Int 24:110–112, 1983.
McCarthy JT, Libertin CR, Mitchell JC III, et al.: Hemosiderosis in a dialysis patient. Treatment with hemofiltration and deferoxamine chelation therapy. Mayo Clin Proc 57:439–441, 1982.
Marcus RE, Davies SC, Bantock HM, et al.: Desferrioxamine to improve cardiac function in iron overloaded patients with thalassemia major. Lancet 1:392–393, 1984.
Wolfe L, Olivieri N, Sallan D, et al.: Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major. N Engl J Med 312:1600–1603, 1985.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Kluwer Academic Publishers
About this chapter
Cite this chapter
Winchester, J.F. (1991). Acute Drug Intoxications. In: Suki, W.N., Massry, S.G. (eds) Therapy of Renal Diseases and Related Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0689-4_40
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0689-4_40
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8027-9
Online ISBN: 978-1-4613-0689-4
eBook Packages: Springer Book Archive